Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora
- 1 July 1988
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 56 (7) , 1730-1737
- https://doi.org/10.1128/iai.56.7.1730-1737.1988
Abstract
Anti-.alpha.-galactosyl immunoglobulin G (anti-Gal) is a natural antibody present in unusually high amounts in human sera. It constitutes as much as 1% of circulating immunoglobulin G in humans and displays a distinct specificity for the carbohydrate epitope galactosyl .alpha.(1 .fwdarw. 3) galactosyl (Gal.alpha.1 .fwdarw. 3Gal). Recently, it has been suggested by various investigators that anti-Gal may be related to some autoimmune phenomena, since marked elevation of its titer was found in sera of patients with autoimmune thyroid disorders, rheumatoid arthritis, glomerulonephritis, and Chagas'' disease. In view of the ubiquitous presence of anti-Gal in high titers in humans, throughout life, we hypothesized that, analogous with synthesis of anti-blood group antibodies against bacterial antigens, bacteria within normal intestinal flora may provide constant antigenic stimulation for the synthesis of anti-Gal. This hypothesis would imply that anti-Gal may bind to a variety of bacterial strains of human flora. In the present study, the interaction between affinity chromatography-purified anti-Gal and various bacterial strains was studied. By the use of a direct immunostaining assay and an enzyme-linked immunosorbent assay, anti-Gal was found to interact with a variety of Escherichia coli, Klebsiella, and Salmonella strains, some of which were isolates from normal stool. Furthermore, the anti-Gal-binding sites in some strains were found to be present on the carbohydrate portion of bacterial lipopolysaccharides. It is thus suggested that Gal.alpha.1 .fwdarw. 3Gal epitopes in the outer membranes of normal flora enterobacteria may provide a continuous source for antigenic stimulation. Since there is no immune tolerance to the Gal.alpha.1 .fwdarw. 3Gal carbohydrate structure in humans, anti-Gal seems to be constantly produced in response to these enterobacteria. In addition, bacteria which express Gal.alpha. .fwdarw. 3Gal epitopes and which may adhere to various cells mediated binding of anti-Gal to human cell lines. These findings raise the possibility that anti-Gal may damage normal human tissues via inflammatory processes facilitated by bacterial Gal.alpha.1 .fwdarw. 3Gal epitopes.This publication has 46 references indexed in Scilit:
- Circulating antibodies to mouse laminin in Chagas disease, American cutaneous leishmaniasis, and normal individuals recognize terminal galactosyl(alpha 1-3)-galactose epitopes.The Journal of Experimental Medicine, 1987
- Anti-α-galactosyl antibodies and immune complexes in children with Henoch–Schönlein purpura or IgA nephropathyKidney International, 1987
- Elevated antigalactosyl antibody titers reflect renal injury after gold or d-penicillamine in rheumatoid arthritisClinical Immunology and Immunopathology, 1986
- The natural anti‐α‐galactosyl IgG on human normal senescent red blood cellsBritish Journal of Haematology, 1986
- Excessive binding of natural anti-alpha-galactosyl immunoglobin G to sickle erythrocytes may contribute to extravascular cell destruction.Journal of Clinical Investigation, 1986
- α-D-Galactosyltransferase activity in calf thymus: A high-resolution 1H-NMR studyBiochemical and Biophysical Research Communications, 1983
- Structural Studies of the Klebsiella O Group 8 Lipopolysaccharide.Acta Chemica Scandinavica, 1973
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- Phospholipid-requiring bacterial enzyme. I. Purification and properties of uridine diphosphate galactose: lipopolysaccharide α-3-galactosyl transferaseBiochemistry, 1969
- Blood group isoantibody stimulation in man by feeding blood group-active bacteriaJournal of Clinical Investigation, 1969